Synthesis and Structural Elucidation of a Pyranomorphinan Opioid and in Vitro Studies

During optimization of the synthesis of the mixed μ opioid agonist/δ opioid antagonist 5-(hydroxy­methyl)­oxy­morphone (UMB425) for scale-up, it was unexpectedly discovered that the 4,5-epoxy bridge underwent rearrangement on treatment with boron tribromide (BBr3) to yield a novel opioid with a litt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Organic letters 2018-05, Vol.20 (10), p.2984-2987
Hauptverfasser: Ansari, Mohd. Imran, Healy, Jason R, Hom, Kellie, Deschamps, Jeffrey R, Matsumoto, Rae R, Coop, Andrew
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:During optimization of the synthesis of the mixed μ opioid agonist/δ opioid antagonist 5-(hydroxy­methyl)­oxy­morphone (UMB425) for scale-up, it was unexpectedly discovered that the 4,5-epoxy bridge underwent rearrangement on treatment with boron tribromide (BBr3) to yield a novel opioid with a little-studied pyranomorphinan skeleton. This finding opens the pyranomorphinans for further investigations of their pharmacological profiles and represents a novel drug class with the dual profile (μ vs δ) predicted to yield lower tolerance and dependence. The structure was assigned with the help of 1D, 2D NMR and the X-ray crystal structure.
ISSN:1523-7060
1523-7052
DOI:10.1021/acs.orglett.8b01025